Literature DB >> 9345101

The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases.

H C Tsou1, D H Teng, X L Ping, V Brancolini, T Davis, R Hu, X X Xie, A C Gruener, C A Schrager, A M Christiano, C Eng, P Steck, J Ott, S V Tavtigian, M Peacocke.   

Abstract

Cowden syndrome (CS) is an autosomal dominant disorder associated with the development of hamartomas and benign tumors in a variety of tissues, including the skin, thyroid, breast, endometrium, and brain. It has been suggested that women with CS are at increased risk for breast cancer. A locus for CS was recently defined on chromosome 10 in 12 families, resulting in the identification of the CS critical interval, between the markers D10S215 and D10S541. More recently, affected individuals in four families with CS have been shown to have germ-line mutations in a gene known as "PTEN," or "MMAC1," which is located in the CS critical interval on chromosome 10. In this study, we report three novel MMAC1 mutations in CS and demonstrate that MMAC1 mutations are associated with CS and breast cancer. Furthermore, we also show that certain families and individuals with CS do not have mutations in the coding sequence of MMAC1. Finally, we did not detect MMAC1 mutations in a subpopulation of individuals with early-onset breast cancer, suggesting that germ-line mutations in this gene do not appear to be common in this group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345101      PMCID: PMC1716044          DOI: 10.1086/301607

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

Review 1.  Cowden syndrome and Lhermitte-Duclos disease.

Authors:  S Albrecht; R M Haber; J C Goodman; M Duvic
Journal:  Cancer       Date:  1992-08-15       Impact factor: 6.860

2.  Age at onset as an indicator of familial risk of breast cancer.

Authors:  E B Claus; N J Risch; W D Thompson
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

3.  Trichilemmomas in Cowden's disease.

Authors:  M H Brownstein; A H Mehregan; J B Bilowski
Journal:  JAMA       Date:  1977-07-04       Impact factor: 56.272

4.  Cowden's disease: a further indication for prophylactic mastectomy.

Authors:  B J Walton; W D Morain; R D Baughman; A Jordan; R W Crichlow
Journal:  Surgery       Date:  1986-01       Impact factor: 3.982

5.  Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.

Authors:  T Fornander; L E Rutqvist; B Cedermark; U Glas; A Mattsson; C Silfverswärd; L Skoog; A Somell; T Theve; N Wilking
Journal:  Lancet       Date:  1989-01-21       Impact factor: 79.321

6.  Cowden's disease: a cutaneous marker of breast cancer.

Authors:  M H Brownstein; M Wolf; J B Bikowski
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Localization of one gene for tuberous sclerosis within 9q32-9q34, and further evidence for heterogeneity.

Authors:  J L Haines; M P Short; D J Kwiatkowski; A Jewell; E Andermann; B Bejjani; C H Yang; J F Gusella; J A Amos
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

9.  Multiple hamartoma syndrome (Cowden's disease).

Authors:  P E Weary; R J Gorlin; W C Gentry; J E Comer; K E Greer
Journal:  Arch Dermatol       Date:  1972-11

10.  The Cowden syndrome: a clinical and genetic study in 21 patients.

Authors:  T M Starink; J P van der Veen; F Arwert; L P de Waal; G G de Lange; J J Gille; A W Eriksson
Journal:  Clin Genet       Date:  1986-03       Impact factor: 4.438

View more
  28 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Pten, a protean tumor suppressor.

Authors:  G L Mutter
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  Polymorphisms in PTEN in breast cancer families.

Authors:  B T Carroll; F J Couch; T R Rebbeck; B L Weber
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

4.  Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters.

Authors:  C Eng; H Ji
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

5.  Male breast cancer in Cowden syndrome patients with germline PTEN mutations.

Authors:  J D Fackenthal; D J Marsh; A L Richardson; S A Cummings; C Eng; B G Robinson; O I Olopade
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

6.  Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.

Authors:  I De Vivo; D M Gertig; S Nagase; S E Hankinson; R O'Brien; F E Speizer; R Parsons; D J Hunter
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

7.  Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN.

Authors:  J T Celebi; H C Tsou; F F Chen; H Zhang; X L Ping; M G Lebwohl; J Kezis; M Peacocke
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

Review 8.  Clinical management of hereditary breast cancer syndromes.

Authors:  Amy S Clark; Susan M Domchek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-01       Impact factor: 2.673

9.  Identification of PTEN mutations in metastatic melanoma specimens.

Authors:  J T Celebi; I Shendrik; D N Silvers; M Peacocke
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

10.  Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.

Authors:  L S Steelman; P M Navolanic; M L Sokolosky; J R Taylor; B D Lehmann; W H Chappell; S L Abrams; E W T Wong; K M Stadelman; D M Terrian; N R Leslie; A M Martelli; F Stivala; M Libra; R A Franklin; J A McCubrey
Journal:  Oncogene       Date:  2008-03-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.